Brief: Charmacy Pharmaceutical Sees Net Profit Attributable For 11 Months Of RMB32 Million
20/12/2022 15:12
Dec 20 (Reuters) - Charmacy Pharmaceutical Co Ltd
2289.HK :
* SEES NET PROFIT ATTRIBUTABLE FOR 11 MONTHS OF RMB32
MILLION
* EXPECTED INCREASE IN NET PROFIT DUE TO INCREASE IN REVENUE
FROM
LOW BASES
Further company coverage: 2289.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Charmacy Pharmaceutical Co
See all newsBrief: Charmacy Pharmaceutical Sees Decrease In Net Profit Attributable By 45% For Year
Brief: Charmacy Pharmaceutical Says Yao Chuanglong Ceased To Be Chairman
Brief: Charmacy Pharmaceutical Posts FY Operating Revenue RMB4,175.28 Million
Brief: Charmacy Pharmaceutical Says Controlling Shareholder To Provide Loan Facility
Brief: Charmacy Pharmaceutical Says Applied For Trading Resumption From Feb 17